Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Am J Obstet Gynecol. 2012 Aug 16;207(5):398.e1–398.e8. doi: 10.1016/j.ajog.2012.08.015

FIGURE 2. Plasma 17-OHPC concentrations (mean ± SD) in 18 subjects who underwent the PK 2 study after the final injection of 17-OHPC.

FIGURE 2

Samples were obtained daily during the pharmacokinetic 2 study and 7 times between days 9–28 after the last injection.

PK, pharmacokinetic; 17-OHPC, 17-hydroxyprogesterone caproate.

Caritis. Pharmacology and placental transport of 17-OHPC. Am J Obstet Gynecol 2012.

HHS Vulnerability Disclosure